{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:36:15Z","timestamp":1759962975013},"reference-count":14,"publisher":"American Association for Cancer Research (AACR)","issue":"12","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Purpose: Prostate cancer is a major cause of cancer death among men and the development of new biomarkers is important to augment current detection approaches.<\/jats:p>\n               <jats:p>Experimental Design: We identified hypermethylation of the ssDNA-binding protein 2 (SSBP2) promoter as a potential DNA marker for human prostate cancer based on previous bioinformatics results and pharmacologic unmasking microarray. We then did quantitative methylation-specific PCR in primary prostate cancer tissues to confirm hypermethylation of the SSBP2 promoter, and analyzed its correlation with clinicopathologic data. We further examined SSBP2 expression in primary prostate cancer and studied its role in cell growth.<\/jats:p>\n               <jats:p>Results: Quantitative methylation-specific PCR results showed that the SSBP2 promoter was hypermethylated in 54 of 88 (61.4%) primary prostate cancers versus 0 of 23 (0%) in benign prostatic hyperplasia using a cutoff value of 120. Furthermore, we found that expression of SSBP2 was down-regulated in primary prostate cancers and cancer cell lines. Hypermethylation of the SSBP2 promoter and its expression were closely associated with higher stages of prostate cancer. Reactivation of SSBP2 expression by the demethylating agent 5-aza-2\u2032-deoxycytidine in prostate cancer cell lines confirmed epigenetic inactivation as one major mechanism of SSBP2 regulation. Moreover, forced expression of SSBP2 inhibited prostate cancer cell proliferation in the colony formation assay and caused cell cycle arrest.<\/jats:p>\n               <jats:p>Conclusion: SSBP2 inhibits prostate cancer cell proliferation and seems to represent a novel prostate cancer\u2013specific DNA marker, especially in high stages of human prostate cancer.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-07-4763","type":"journal-article","created":{"date-parts":[[2008,6,16]],"date-time":"2008-06-16T18:33:36Z","timestamp":1213641216000},"page":"3754-3760","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["ssDNA-Binding Protein 2 Is Frequently Hypermethylated and Suppresses Cell Growth in Human Prostate Cancer"],"prefix":"10.1158","volume":"14","author":[{"given":"Jun-Wei","family":"Liu","sequence":"first","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"Jatin K.","family":"Nagpal","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"Wenyue","family":"Sun","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"Juna","family":"Lee","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"Myoung Sook","family":"Kim","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"Kimberly L.","family":"Ostrow","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"Shaoyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"Carmen","family":"Jeronimo","sequence":"additional","affiliation":[{"name":"2Departments of Genetics and Pathology, Portuguese Oncology Institute-Porto, Porto, Portugal; and"}]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[{"name":"2Departments of Genetics and Pathology, Portuguese Oncology Institute-Porto, Porto, Portugal; and"}]},{"given":"Wim","family":"Van Criekinge","sequence":"additional","affiliation":[{"name":"3OncoMethylome Sciences S.A., Liege, Belgium"}]},{"given":"Chu So","family":"Moon","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"Joseph A.","family":"Califano","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"Barry","family":"Trink","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]},{"given":"David","family":"Sidransky","sequence":"additional","affiliation":[{"name":"1Division of Head and Neck Cancer Research, Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}]}],"member":"1086","published-online":{"date-parts":[[2008,6,16]]},"reference":[{"key":"2022061021435340900_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin\u20082007;57:43\u201366.","DOI":"10.3322\/canjclin.57.1.43"},{"key":"2022061021435340900_B2","doi-asserted-by":"crossref","unstructured":"Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer\u20082002;2:210\u20139.","DOI":"10.1038\/nrc755"},{"key":"2022061021435340900_B3","doi-asserted-by":"crossref","unstructured":"Li LC, Carroll PR, Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst\u20082005;97:103\u201315.","DOI":"10.1093\/jnci\/dji010"},{"key":"2022061021435340900_B4","doi-asserted-by":"crossref","unstructured":"Jeronimo C, Usadel H, Henrique R, et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst\u20082001;93:1747\u201352.","DOI":"10.1093\/jnci\/93.22.1747"},{"key":"2022061021435340900_B5","doi-asserted-by":"crossref","unstructured":"Jeronimo C, Henrique R, Hoque MO, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res\u20082004;10:8472\u20138.","DOI":"10.1158\/1078-0432.CCR-04-0894"},{"key":"2022061021435340900_B6","doi-asserted-by":"crossref","unstructured":"Yegnasubramanian S, Kowalski J, Gonzalgo ML, et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res\u20082004;64:1975\u201386.","DOI":"10.1158\/0008-5472.CAN-03-3972"},{"key":"2022061021435340900_B7","doi-asserted-by":"crossref","unstructured":"Kang GH, Lee S, Lee HJ, Hwang KS. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol\u20082004;202:233\u201340.","DOI":"10.1002\/path.1503"},{"key":"2022061021435340900_B8","doi-asserted-by":"crossref","unstructured":"Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer\u20082005;5:223\u201331.","DOI":"10.1038\/nrc1571"},{"key":"2022061021435340900_B9","doi-asserted-by":"crossref","unstructured":"Bayarsaihan D, Soto RJ, Lukens LN. Cloning and characterization of a novel sequence-specific single-stranded-DNA-binding protein. Biochem J\u20081998;331 (Pt 2):447\u201352.","DOI":"10.1042\/bj3310447"},{"key":"2022061021435340900_B10","doi-asserted-by":"crossref","unstructured":"Fairman J, Wang RY, Liang H, et al. Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus. Blood\u20081996;88:2259\u201366.","DOI":"10.1182\/blood.V88.6.2259.bloodjournal8862259"},{"key":"2022061021435340900_B11","doi-asserted-by":"crossref","unstructured":"Castro PD, Liang JC, Nagarajan L. Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms. Blood\u20082000;95:2138\u201343.","DOI":"10.1182\/blood.V95.6.2138"},{"key":"2022061021435340900_B12","doi-asserted-by":"crossref","unstructured":"Liang H, Samanta S, Nagarajan L. SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells. Oncogene\u20082005;24:2625\u201334.","DOI":"10.1038\/sj.onc.1208167"},{"key":"2022061021435340900_B13","doi-asserted-by":"crossref","unstructured":"Liu JW, Kim MS, Nagpal J, et al. Quantitative hypermethylation of NMDAR2B in human gastric cancer. Int J of Cancer\u20082007;121:1994\u20132000.","DOI":"10.1002\/ijc.22934"},{"key":"2022061021435340900_B14","doi-asserted-by":"crossref","unstructured":"Hoque MO, Kim MS, Ostro KL, et al. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res\u20082008;68:2661\u201370.","DOI":"10.1158\/0008-5472.CAN-07-5913"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/14\/12\/3754\/1975557\/3754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/14\/12\/3754\/1975557\/3754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T02:55:29Z","timestamp":1654916129000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/14\/12\/3754\/72759\/ssDNA-Binding-Protein-2-Is-Frequently"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,15]]},"references-count":14,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2008,6,16]]},"published-print":{"date-parts":[[2008,6,15]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-07-4763","relation":{},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,15]]}}}